Mark Petersen | Future Pharma Europe

Day 1 | 20th October

Why is pharma's focus on omnichannel and optichannel potentially reinforcing outdated, channel-first thinking rather than improving HCP engagement?
What does the reality of optichannel look like inside organisations, and why do fragmented journeys and activity-based KPIs still persist?
How can leaders move away from channel optimisation toward truly customer-centric engagement models that prioritise outcomes over activity?
As AI-driven engagement accelerates, could manual channel selection become obsolete, and where should pharma leaders be investing instead?

Check out the incredible speaker line-up to see who will be joining Mark.